These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17141460)

  • 41. Culture enrichment assists the diagnosis of cattle botulism by a monoclonal antibody based sandwich ELISA.
    Brooks CE; Clarke HJ; Finlay DA; McConnell W; Graham DA; Ball HJ
    Vet Microbiol; 2010 Jul; 144(1-2):226-30. PubMed ID: 20116183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linden flower (Tilia spp.) as potential vehicle of Clostridium botulinum spores in the transmission of infant botulism.
    Bianco MI; Lúquez C; De Jong LI; Fernández RA
    Rev Argent Microbiol; 2009; 41(4):232-6. PubMed ID: 20085187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid and sensitive detection of biological warfare agents using time-resolved fluorescence assays.
    Peruski AH; Johnson LH; Peruski LF
    J Immunol Methods; 2002 May; 263(1-2):35-41. PubMed ID: 12009202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxin detection in patients' sera by mass spectrometry during two outbreaks of type A Botulism in France.
    Mazuet C; Ezan E; Volland H; Popoff MR; Becher F
    J Clin Microbiol; 2012 Dec; 50(12):4091-4. PubMed ID: 22993181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clostridium botulinum and the clinical laboratorian: a detailed review of botulism, including biological warfare ramifications of botulinum toxin.
    Caya JG; Agni R; Miller JE
    Arch Pathol Lab Med; 2004 Jun; 128(6):653-62. PubMed ID: 15163234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of a clinical assay for botulinum neurotoxins through mass spectrometric detection.
    Hoyt KM; Barr JR; Hopkins AO; Dykes JK; Lúquez C; Kalb SR
    J Clin Microbiol; 2024 Jun; 62(6):e0162923. PubMed ID: 38687021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical aspects of biologic toxins.
    Marks JD
    Anesthesiol Clin North Am; 2004 Sep; 22(3):509-32, vii. PubMed ID: 15325716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Botulism has not disappeared].
    Gentil A; Soichot P; Maugras C; Lemesle-Martin M; Béjot Y; Rouaud O; Osseby GV; Fromont A; Couvreur G; Moreau T; Giroud M
    Presse Med; 2008 May; 37(5 Pt 1):789-92. PubMed ID: 18249520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulism and bioterrorism: how serious is this problem?
    Patocka J; Splino M; Merka V
    Acta Medica (Hradec Kralove); 2005; 48(1):23-8. PubMed ID: 16080379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of botulinum toxin type in clinical samples and foods in Iran.
    Shahcheraghi F; Nobari S; Masoumi Asl H; Aslani MM
    Arch Iran Med; 2013 Nov; 16(11):642-6. PubMed ID: 24206405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunomagnetic beads assay for the detection of botulinum neurotoxin types C and D.
    Gessler F; Hampe K; Schmidt M; Böhnel H
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):225-32. PubMed ID: 16839735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Detection of Clostridium botulinum toxin in the blood of patients and in meat products].
    Radosavljević MK
    Vojnosanit Pregl; 1990; 47(6):419-21. PubMed ID: 2075704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Bovine botulism: laboratory confirmation of clinical diagnosis in 1986-1989].
    Baldassi L; Hipolito M; Portugal MA; Calil EM; Moulin AA; Pires Dde C
    Rev Saude Publica; 1991 Oct; 25(5):371-4. PubMed ID: 1820626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel assays for the detection of botulinum toxins in foods.
    Wictome M; Newton KA; Jameson K; Dunnigan P; Clarke S; Gaze J; Tauk A; Foster KA; Shone CC
    Dev Biol Stand; 1999; 101():141-5. PubMed ID: 10566787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasensitive detection of protease activity of anthrax and botulinum toxins by a new PCR-based assay.
    Kolesnikov AV; Kozyr AV; Ryabko AK; Shemyakin IG
    Pathog Dis; 2016 Feb; 74(1):ftv112. PubMed ID: 26620058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: collaborative study.
    Ferreira JL; Maslanka S; Johnson E; Goodnough M
    J AOAC Int; 2003; 86(2):314-31. PubMed ID: 12723917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of amplified ELISA and mouse bioassay procedures for determination of botulinal toxins A, B, E, and F.
    Ferreira JL
    J AOAC Int; 2001; 84(1):85-8. PubMed ID: 11234855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case report on human type B botulism.
    Takahashi M; Tokumaru Y; Yamamoto M; Shimizu T; Kondo H; Ishihara N; Okubo T; Sato T; Sakaguchi G
    Jpn J Med Sci Biol; 1986 Feb; 39(1):29-33. PubMed ID: 3735765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid diagnosis of a case of infant botulism by enzyme immunoassay.
    Dezfulian M; Yolken R; Bartlett J
    Pediatr Infect Dis; 1985; 4(4):399-401. PubMed ID: 3895179
    [No Abstract]   [Full Text] [Related]  

  • 60. An Ultrasensitive Gold Nanoparticle-based Lateral Flow Test for the Detection of Active Botulinum Neurotoxin Type A.
    Liu J; Gao S; Kang L; Ji B; Xin W; Kang J; Li P; Gao J; Wang H; Wang J; Yang H
    Nanoscale Res Lett; 2017 Dec; 12(1):227. PubMed ID: 28359137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.